OpenURL Connection Search

Select item for more details and to access through your institution.

Response to neoadjuvant chemotherapy and the 21-gene Breast Recurrence Score test in young women with estrogen receptor-positive early breast cancer.
Published in:
Breast Cancer Research & Treatment, 2021, v. 186, n. 1, p. 157, doi. 10.1007/s10549-020-05989-5
By:
- Sella, Tal;
- Gelber, Shari I.;
- Poorvu, Philip D.;
- Kim, Hee-Jeong;
- Dominici, Laura;
- Guzman-Arocho, Yaileen D.;
- Collins, Laura;
- Ruddy, Kathryn J.;
- Tamimi, Rulla M.;
- Peppercorn, Jeffrey M.;
- Schapira, Lidia;
- Borges, Virginia F.;
- Come, Steven E.;
- Warner, Ellen;
- Snow, Craig;
- Jakubowski, Debbie M.;
- Russell, Christy A.;
- Winer, Eric P.;
- Rosenberg, Shoshana M.;
- Partridge, Ann H.
Publication type:
Article
Genomic comparison of paired primary breast carcinomas and lymph node macrometastases using the Oncotype DX Breast Recurrence Score<sup>®</sup> test.
Published in:
Breast Cancer Research & Treatment, 2019, v. 177, n. 3, p. 611, doi. 10.1007/s10549-019-05346-1
By:
- Boolbol, Susan K.;
- Harshan, Manju;
- Chadha, Manjeet;
- Kirstein, Laurie;
- Cohen, Jean-Marc;
- Klein, Paula;
- Anderson, Joseph;
- Davison, Deborah;
- Jakubowski, Debbie M.;
- Baehner, Frederick L.;
- Malamud, Stephen
Publication type:
Article
Validation of the 21-gene test as a predictor of clinical response to neoadjuvant hormonal therapy for ER+, HER2-negative breast cancer: the TransNEOS study.
Published in:
Breast Cancer Research & Treatment, 2019, v. 173, n. 1, p. 123, doi. 10.1007/s10549-018-4964-y
By:
- Iwata, Hiroji;
- Masuda, Norikazu;
- Yamamoto, Yutaka;
- Fujisawa, Tomomi;
- Toyama, Tatsuya;
- Kashiwaba, Masahiro;
- Ohtani, Shoichiro;
- Taira, Naruto;
- Sakai, Takehiko;
- Hasegawa, Yoshie;
- Nakamura, Rikiya;
- Akabane, Hiromitsu;
- Shibahara, Yukiko;
- Sasano, Hironobu;
- Yamaguchi, Takuhiro;
- Sakamaki, Kentaro;
- Bailey, Helen;
- Cherbavaz, Diana B.;
- Jakubowski, Debbie M.;
- Sugiyama, Naoko
Publication type:
Article
Ten-year clinical outcomes in N0 ER+ breast cancer patients with Recurrence Score-guided therapy.
Published in:
NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-019-0137-3
By:
- Stemmer, Salomon M.;
- Steiner, Mariana;
- Rizel, Shulamith;
- Ben-Baruch, Noa;
- Uziely, Beatrice;
- Jakubowski, Debbie M.;
- Baron, Julie;
- Shak, Steven;
- Soussan-Gutman, Lior;
- Bareket-Samish, Avital;
- Fried, Georgeta;
- Rosengarten, Ora;
- Itay, Amit;
- Nisenbaum, Bella;
- Katz, Daniela;
- Leviov, Michelle;
- Tokar, Margarita;
- Liebermann, Nicky;
- Geffen, David B.
Publication type:
Article
Molecular characterization of breast cancer needle core biopsy specimens by the 21‐gene Breast Recurrence Score test.
Published in:
Journal of Surgical Oncology, 2020, v. 122, n. 4, p. 611, doi. 10.1002/jso.26050
By:
- Jakubowski, Debbie M.;
- Bailey, Helen;
- Abran, John;
- Blacklock, Andrea;
- Ciau, Nancy;
- Mies, Carolyn;
- Tan, Vivian;
- Young, Rebekah;
- Lau, Anna;
- Baehner, Frederick L.
Publication type:
Article

Found: 5

Response to neoadjuvant chemotherapy and the 21-gene Breast Recurrence Score test in young women with estrogen receptor-positive early breast cancer.

Genomic comparison of paired primary breast carcinomas and lymph node macrometastases using the Oncotype DX Breast Recurrence Score<sup>®</sup> test.

Validation of the 21-gene test as a predictor of clinical response to neoadjuvant hormonal therapy for ER+, HER2-negative breast cancer: the TransNEOS study.

Ten-year clinical outcomes in N0 ER+ breast cancer patients with Recurrence Score-guided therapy.

Molecular characterization of breast cancer needle core biopsy specimens by the 21‐gene Breast Recurrence Score test.